🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this protocol is to evaluate the efficacy of tulisokibart in...
Status
Active Not Recruiting
Location
Digestive Health Specialists ( Site 0135)
Start Date
2023-10-25
Trial ID
NCT06052059
Treatments Being Tested
The goal of this study is to learn about the safety of tulisokibart in heal...
Status
Completed
Location
Peking University Third Hospital (Site 0001)
Start Date
2024-06-13
Trial ID
NCT06829225
Treatments Being Tested
Researchers are looking for new ways to treat rheumatoid arthritis (RA). Me...
Status
Active Not Recruiting
Location
Arizona Arthritis & Rheumatology Associates, P.C. ( Site 1018)
Start Date
2025-10-08
Trial ID
NCT07176390
Treatments Being Tested
Researchers want to learn more about tulisokibart (also known as MK-7240) i...
Status
Recruiting
Location
Connecticut Clinical Research Institute ( Site 0297)
Start Date
2024-11-25
Trial ID
NCT06651281
Treatments Being Tested
Researchers are looking for new ways to treat radiographic axial spondyloar...
Status
Recruiting
Location
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Chandler ( Site 0036)
Start Date
2025-09-26
Trial ID
NCT07133633
Treatments Being Tested
The primary objectives of the study are to characterize the pharmacokinetic...
Status
Completed
Location
QPS Missouri ( Site 0003)
Start Date
2024-09-24
Trial ID
NCT06575595
Treatments Being Tested
This is a phase 2b randomized, double-blind, placebo-controlled study of th...
Status
Active Not Recruiting
Location
Cahaba Dermatology & Skin Health Center ( Site 0012)
Start Date
2025-06-09
Trial ID
NCT06956235
Treatments Being Tested
The purpose of this protocol is to evaluate the efficacy and safety of tuli...
Status
Recruiting
Location
Digestive Health Specialists ( Site 5064)
Start Date
2024-06-05
Trial ID
NCT06430801
Treatments Being Tested